Tags: Regeneron Pharmaceuticals

Summary of Regeneron Pharmaceuticals, Inc. (REGN) | Monday July 17, 2017 Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN), from Healthcare sector has been on the upside of the performance spectrum. Regeneron Pharmaceuticals, Inc. stated a price of 504.9 today, indicating a positive change of -0.03%. Regeneron Pharmaceuticals, Inc. is operating with a market capitalization of 53.68 B, with a return on assets…

Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) | Friday July 14, 2017 With a market cap of 54.43 B, Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) has a large market cap size. Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) has been on the stock market since its IPO date on the 04/02/1991. Regeneron Pharmaceuticals, Inc. is in the Biotechnology industry and Healthcare sector. Average volume for…

Outlined as the total market value of all unsettled shares of the company, the current market cap for the Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) Biotechnology is valued at 53.56 B. The dominant statistics will authorize the investment community to govern the size of Regeneron Pharmaceuticals, Inc. compared to the sales or total assets figures. Consequently, investors will be able…

Outlined as the total market value of all unsettled shares of the company, the current market cap for the Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) Biotechnology is valued at 53.02 B. The dominant statistics will authorize the investment community to govern the size of Regeneron Pharmaceuticals, Inc. compared to the sales or total assets figures. Consequently, investors will be able…

Outlined as the total market value of all unsettled shares of the company, the current market cap for the Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) Biotechnology is valued at 53.51 B. The dominant statistics will authorize the investment community to govern the size of Regeneron Pharmaceuticals, Inc. compared to the sales or total assets figures. Consequently, investors will be able…

Summary of Regeneron Pharmaceuticals, Inc. (REGN) | Friday July 7, 2017 Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN), from Healthcare sector has been on the upside of the performance spectrum. Regeneron Pharmaceuticals, Inc. stated a price of 495.61 today, indicating a positive change of 1.11%. Regeneron Pharmaceuticals, Inc. is operating with a market capitalization of 54.1 B, with a return on assets…

Outlined as the total market value of all unsettled shares of the company, the current market cap for the Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) Biotechnology is valued at 54.85 B. The dominant statistics will authorize the investment community to govern the size of Regeneron Pharmaceuticals, Inc. compared to the sales or total assets figures. Consequently, investors will be able…

Summary of Regeneron Pharmaceuticals, Inc. (REGN) | Wednesday July 5, 2017 Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN), from Healthcare sector has been on the upside of the performance spectrum. Regeneron Pharmaceuticals, Inc. stated a price of 496.1 today, indicating a positive change of 1.72%. Regeneron Pharmaceuticals, Inc. is operating with a market capitalization of 53.83 B, with a return on assets…

Outlined as the total market value of all unsettled shares of the company, the current market cap for the Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) Biotechnology is valued at 53.83 B. The dominant statistics will authorize the investment community to govern the size of Regeneron Pharmaceuticals, Inc. compared to the sales or total assets figures. Consequently, investors will be able…

Summary of Regeneron Pharmaceuticals, Inc. (REGN) | Monday July 3, 2017 Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN), from Healthcare sector has been on the upside of the performance spectrum. Regeneron Pharmaceuticals, Inc. stated a price of 488.07 today, indicating a positive change of -0.63%. Regeneron Pharmaceuticals, Inc. is operating with a market capitalization of 54.2 B, with a return on assets…